search
Back to results

Feasibility Study on the Impact of Economic Incentives to Improve the Management of Type 2 Diabetes Mellitus (REDEEM-Pilot)

Primary Purpose

Diabetes Mellitus, Type 2

Status
Completed
Phase
Not Applicable
Locations
Peru
Study Type
Interventional
Intervention
Diabetes education
Goal setting
Companion Support
Individual Reward
Shared Reward
Sponsored by
Universidad Peruana Cayetano Heredia
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Diabetes Mellitus, Type 2 focused on measuring Diabetes Mellitus, Type 2, Weight Loss, Financial Incentives, Hemoglobin A, Glycosylated

Eligibility Criteria

18 Years - 70 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion criteria for participants:

  • Type 2 diabetes mellitus
  • Body mass index 25-39.9 kg/m2, irrespective of HbA1c status
  • Able to give consent

Exclusion Criteria for participants:

  • Diagnosis of cancer or another serious comorbidity
  • Pharmacotherapy for weight loss or corticosteroids
  • Pregnant women
  • Blindness, amputation, foot ulcer or being on dialysis
  • Be companion/team support for another participant in the trial

Inclusion criteria for the companion/team support:

  • Available and committed to supporting the participant in achieving their goals
  • Able to provide consent

Exclusion criteria for the companion/team support:

  • Physical or mental condition that does not allow him to help the participant to achieve goals

Sites / Locations

  • Hospital Nacional Arzobispo Loayza

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Experimental

Experimental

Arm Label

Individual incentives - Arm 1

Mixed incentives (Altruism) - Arm 2

Mixed Incentives (Cooperation) - Arm 3

Arm Description

This arm receives diabetes education + goal setting + individual rewards

This arm receives diabetes education + goal setting + companion support + individual rewards

This arm receives diabetes education + goal setting + companion support + shared rewards

Outcomes

Primary Outcome Measures

Glycated hemoglobin
HbA1c change at 3 months from baseline

Secondary Outcome Measures

Weight loss
Weight and BMI change at 3 months from baseline

Full Information

First Posted
August 31, 2016
Last Updated
January 17, 2018
Sponsor
Universidad Peruana Cayetano Heredia
Collaborators
Johns Hopkins Bloomberg School of Public Health
search

1. Study Identification

Unique Protocol Identification Number
NCT02891382
Brief Title
Feasibility Study on the Impact of Economic Incentives to Improve the Management of Type 2 Diabetes Mellitus
Acronym
REDEEM-Pilot
Official Title
Feasibility Study on the Impact of Economic Incentives for Weight Loss to Improve the Management of Type 2 Diabetes Mellitus: REDEEM Feasibility Study
Study Type
Interventional

2. Study Status

Record Verification Date
January 2018
Overall Recruitment Status
Completed
Study Start Date
July 2016 (undefined)
Primary Completion Date
February 2017 (Actual)
Study Completion Date
February 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Universidad Peruana Cayetano Heredia
Collaborators
Johns Hopkins Bloomberg School of Public Health

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
This feasibility study aims to compare the implementation process of three different interventions that use economic incentives to promote lifestyle behavioral changes in patients with type 2 diabetes mellitus, and to identify barriers and facilitators linked to the process of implementing each of the interventions. The interventions are based on economic incentives directed to the patient (individual incentives) or a team comprised by the patient and a partner (mixed incentives). Design: Three-month randomized control feasibility study to test the feasibility of implementing three types of intervention with economic incentives in patients with diabetes mellitus. Setting: Diabetes outpatient clinics from a public hospital in Peru.
Detailed Description
Economic incentives have been used to promote changes in habits such as smoking and weight loss. However, no studies have been done to determine the impact of this strategy on the management of type 2 diabetes mellitus (T2DM). Additionally, previous studies do not describe ways to determine the amount of an economic incentive to promote behavioral changes, e.g adherence to treatment, increased physical activity and adherence to a healthy diet. There are also questions regarding the frequency of incentives, the type of incentive (cash or other prizes), and the preferred payment method that this study will allow us to explore. Furthermore, we want to test whether a "team work approach" (mixed incentives) vs. an "individual approach" (individual incentives) can also play a role in introducing behavioral changes. The goal of the study is to learn about the implementation process of three different interventions that use economic incentives to promote behavioral changes in patients with T2DM, and identify main barriers and facilitators tied to the implementation process of each intervention. This feasibility study will provide key insights to inform a future larger study; specifically, we will Learn about the experience of participants with T2DM with economic incentives. Learn about the experience of the companion/team support partners of the participants with T2DM. Evaluate the patient's receptiveness to and comprehension of the educational materials used to promote behavioral changes. Evaluate the patient and the companion/team support partner's receptiveness towards the received economic incentive as a tool for promoting behavioral changes. Explore the companion/team support partner's activities that are most effective in helping with T2DM management of patients. Explore whether patients with T2DM are able to keep a daily record of their efforts to manage their diabetes. Evaluate the feasibility of packaging and implementing a future clinical trial that evaluates the impact of the use of economic incentives and teamwork in people with T2DM. From a clinical perspective, we will evaluate the feasibility of reaching the proposed clinical goals in terms of weight loss and HbA1c levels after the intervention period. Interventions Diabetes education (all arms). In the introductory meeting, a diabetes educator will explain to the participants all the procedures, including details of the number of sessions, and the participant's received a manual with information about diabetes management with a tailored weight loss plan. Each participant will be offered up to seven follow- up sessions with the diabetes educator, every two weeks, plus a final session, thus totaling up to 9 one-to-one interactions during the trial, provided that the participant attended all of their meetings. Participants will also be provided with a logbook to register their efforts regarding introducing changes in diet and physical activity. The information from this logbook will provide the starting point for conversations with the diabetes educator during the follow-up sessions, every two weeks. Goal setting (all arms). To determine eligibility for a cash reward, three goals were pre-specified: (1) Weight loss, 80 PEN if the participant loses one kilogram over a period of two weeks, (2) HbA1c level, 200 PEN if the participant achieves, at the end of the study, a decrease in 1% compared to their baseline level, and (3) HbA1c level and control, 400 PEN if the participant achieves, at the end of the study, a decrease ≥1% of A1c or reaches levels of A1c ≤6.5% compared to their baseline level. At the end of the study, targets for weight loss and HbA1c were evaluated independently, i.e. participants could receive more than one reward provided that each independent target was achieved. Companion/team support (Arm 2 and Arm 3). A companion/team support for each participant also receives information about diabetes care in the initial session and a brochure to guide and support the treatment process of the participant. The activities of the companion/team support member will be recorded, and they will be offered to join the follow- up sessions with the patient, every two weeks, but these will not be compulsory. Cash rewards. Two types of rewards will be considered. (1) Individual rewards (Arm 1 and Arm 2), the reward will be provided to the participant. If the participant were to have a companion/team support partner, the cash reward was given to the participant and no rules about sharing the reward (or not) with their companion/team support are established. (2) Shared rewards (Arm 3), i.e. the participant and their companion/team support will receive 50% of the cash reward each.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetes Mellitus, Type 2
Keywords
Diabetes Mellitus, Type 2, Weight Loss, Financial Incentives, Hemoglobin A, Glycosylated

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Investigator
Allocation
Randomized
Enrollment
54 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Individual incentives - Arm 1
Arm Type
Experimental
Arm Description
This arm receives diabetes education + goal setting + individual rewards
Arm Title
Mixed incentives (Altruism) - Arm 2
Arm Type
Experimental
Arm Description
This arm receives diabetes education + goal setting + companion support + individual rewards
Arm Title
Mixed Incentives (Cooperation) - Arm 3
Arm Type
Experimental
Arm Description
This arm receives diabetes education + goal setting + companion support + shared rewards
Intervention Type
Behavioral
Intervention Name(s)
Diabetes education
Intervention Description
Participants interact with a diabetes educator (DE), every two weeks.
Intervention Type
Behavioral
Intervention Name(s)
Goal setting
Intervention Description
Goals for weight loss and change in levels of HbA1c
Intervention Type
Behavioral
Intervention Name(s)
Companion Support
Intervention Description
Patient has a companion/team support partner to support achieving goals.
Intervention Type
Behavioral
Intervention Name(s)
Individual Reward
Intervention Description
The cash reward is given to the patient with diabetes.
Intervention Type
Behavioral
Intervention Name(s)
Shared Reward
Intervention Description
Patients with diabetes and their companion support will each receive 50% of the cash reward.
Primary Outcome Measure Information:
Title
Glycated hemoglobin
Description
HbA1c change at 3 months from baseline
Time Frame
3 months
Secondary Outcome Measure Information:
Title
Weight loss
Description
Weight and BMI change at 3 months from baseline
Time Frame
3 months
Other Pre-specified Outcome Measures:
Title
Feasibility
Description
Feasibility of conducting a three-arm incentives-based pilot study
Time Frame
3 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion criteria for participants: Type 2 diabetes mellitus Body mass index 25-39.9 kg/m2, irrespective of HbA1c status Able to give consent Exclusion Criteria for participants: Diagnosis of cancer or another serious comorbidity Pharmacotherapy for weight loss or corticosteroids Pregnant women Blindness, amputation, foot ulcer or being on dialysis Be companion/team support for another participant in the trial Inclusion criteria for the companion/team support: Available and committed to supporting the participant in achieving their goals Able to provide consent Exclusion criteria for the companion/team support: Physical or mental condition that does not allow him to help the participant to achieve goals
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jaime Miranda, MD, PhD
Organizational Affiliation
Universidad Peruana Cayetano Heredia
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Antonio Trujillo, PhD
Organizational Affiliation
Johns Hopkins Bloomberg School of Public Health
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hospital Nacional Arzobispo Loayza
City
Lima
Country
Peru

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Following on MRC's data sharing policy, we plan to make our quantitative datasets available in platforms for data sharing (e.g. Figshare, etc.). Qualitative data will be available upon request.
IPD Sharing Time Frame
The dataset with quantitative information will be available within six months from the publication of the main manuscript.
IPD Sharing Access Criteria
Contact cronicas@oficinas-upch.pe; maria.pesantes.v@upch.pe; maria.lazo@upch.pe; and/or jaime.miranda@upch.pe
IPD Sharing URL
https://www.mrc.ac.uk/research/policies-and-guidance-for-researchers/data-sharing/
Citations:
PubMed Identifier
30662958
Citation
Miranda JJ, Lazo-Porras M, Bernabe-Ortiz A, Pesantes MA, Diez-Canseco F, Cornejo SDP, Trujillo AJ. The effect of individual and mixed rewards on diabetes management: A feasibility randomized controlled trial. Wellcome Open Res. 2019 Feb 5;3:139. doi: 10.12688/wellcomeopenres.14824.3. eCollection 2018.
Results Reference
derived

Learn more about this trial

Feasibility Study on the Impact of Economic Incentives to Improve the Management of Type 2 Diabetes Mellitus

We'll reach out to this number within 24 hrs